Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective …
S Schreiber, JF Colombel, BG Feagan… - Annals of the …, 2019 - ard.bmj.com
Objectives Here, we present the reported incidence rates of inflammatory bowel disease
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective …
S Schreiber, JF Colombel, BG Feagan… - Annals of the …, 2019 - eprints.gla.ac.uk
Objectives: Here, we present the reported incidence rates of inflammatory bowel disease
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
[PDF][PDF] Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective …
T Fox - 2019 - core.ac.uk
Objectives Here, we present the reported incidence rates of inflammatory bowel disease
(iBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
(iBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
[HTML][HTML] Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a …
S Schreiber, JF Colombel, BG Feagan… - Annals of the …, 2019 - ncbi.nlm.nih.gov
Objectives Here, we present the reported incidence rates of inflammatory bowel disease
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: A retrospective …
S Schreiber, JF Colombel, BG Feagan… - Annals of the …, 2019 - ohsu.elsevierpure.com
Objectives Here, we present the reported incidence rates of inflammatory bowel disease
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective …
S Schreiber, JF Colombel, BG Feagan… - Annals of the …, 2019 - search.proquest.com
Objectives Here, we present the reported incidence rates of inflammatory bowel disease
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
[PDF][PDF] Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective …
S Schreiber, JF Colombel, BG Feagan… - Annals of the …, 2019 - ard.bmj.com
Objectives Here, we present the reported incidence rates of inflammatory bowel disease
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective …
S Schreiber, JF Colombel, BG Feagan… - Annals of the …, 2019 - europepmc.org
Objectives Here, we present the reported incidence rates of inflammatory bowel disease
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective …
S Schreiber, JF Colombel, BG Feagan… - Annals of the …, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objectives</jats: title>< jats: p> Here, we present the reported
incidence rates of inflammatory bowel disease (IBD) in patients receiving treatment with …
incidence rates of inflammatory bowel disease (IBD) in patients receiving treatment with …
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective …
S Schreiber, JF Colombel… - Annals of the …, 2019 - pubmed.ncbi.nlm.nih.gov
Objectives Here, we present the reported incidence rates of inflammatory bowel disease
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …